422545-96-8

Basic information

• Product Name: 2-Pyrrolidineethanamine,1-methyl-,(2R)-(9CI)
• Synonyms: 2-Pyrrolidineethanamine,1-methyl-,(2R)-(9CI);(2R)-1-Methyl-2-pyrrolidineethanamine;2-[(2R)-1-Methylpyrrolidin-2-yl]ethanaMine;(R)-2-(1-Methylpyrrolidin-2-yl)ethanaMine;(R)-1-Methyl-2-pyrrolidineethanamine
• CAS NO: 422545-96-8
• Molecular Formula: C7H16N2
• Molecular Weight: 128.22
• Product Categories: AMINETERTIARY
• Mol File: 422545-96-8.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 152.7 °C at 760 mmHg
• Flash Point: 65 °C
• Appearance: /
• Density: 0.909
• Vapor Pressure: 3.45mmHg at 25°C
• Refractive Index: 1.473
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• CAS DataBase Reference: 2-Pyrrolidineethanamine,1-methyl-,(2R)-(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Pyrrolidineethanamine,1-methyl-,(2R)-(9CI)(422545-96-8)
• EPA Substance Registry System: 2-Pyrrolidineethanamine,1-methyl-,(2R)-(9CI)(422545-96-8)

Safety Data

• Hazardous Substances Data: 422545-96-8(Hazardous Substances Data)

Usage

General Description

2-Pyrrolidineethanamine, 1-methyl, (2R)-(9CI) is a chemical compound with the systematic name 1-methyl-2-pyrrolidineethylamine. It is a chiral amine, meaning it has a non-superimposable mirror image, and it is often used as a building block in the synthesis of pharmaceuticals and other organic compounds. 2-Pyrrolidineethanamine,1-methyl-,(2R)-(9CI) has been found to have potential pharmacological activity, particularly in the treatment of central nervous system disorders. Its unique structure and properties make it a valuable tool in the development of new drugs and medical treatments.

InChI:InChI=1/C7H16N2/c1-9-6-2-3-7(9)4-5-8/h7H,2-6,8H2,1H3/t7-/m1/s1

Upstream product

• 67824-40-2 2-((2R)-1-methylpyrrolidin-2-yl)ethanenitrile 
• 1332848-72-2 (-)-2-(2-aminoethyl)-1-methylpyrrolidine O,O'-di-p-toluoyl-D-tartaric acid salt 
• 51387-90-7 2-(2-AMINOETHYL)-1-METHYLPYRROLIDINE 
• 67824-39-9 2-((2S)-1-methylpyrrolidin-2-yl)ethanenitrile 

Downstream Products

• 422545-95-7 (S)-2-(1-methylpyrrolidin-2-yl)ethan-1-amine 
• 1437772-10-5 N-[2-(1-methylpyrrolidin-2-yl)ethyl]-1-(5-phenylthieno[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamide 
• 1437771-04-4 2-(1-methylpyrrolidin-2-yl)-N-[[1-(5-phenylthieno[2,3-d]pyrimidin-4-yl)-4-piperidyl]methyl]ethanamine 
• 1008505-24-5 4-bromo-N-[2-(1-methylpyrrolidin-2-yl)ethyl]benzamide 
• 1378524-41-4 VUF₁₁₂₀₇ 
• 876059-62-0 5-Fluoro-N-[2-[1-methylpyrrolidin-2(R)-yl]ethyl]-3-oxo-6-[3-(2-pyrazinyl)pyrrolidin-1-yl]-3H-benzo[b]pyrido[3,2,1-kl]phenoxazine-2-carboxamide 
• 865311-47-3 quarfloxacin 

Relevant articles and documents

Absorption medium and method for removing sour gases from fluid streams, in particular from flue gases

Absorption medium for acid gases comprising an oligoamine (A) of the general formula (I) and a primary or secondary alkanolamine (B) of the general formula (II) in which the weight ratio of oligoamine (A) to the primary or secondary alkanolamine (B) is 0.2 to 4, and also the process for removing acid gases from a gas stream by contacting the gas stream at a pressure of 0.05 to 10 MPa abs with an aqueous solution brought to and maintained at a temperature of 20 to 80° C. of said absorption medium.

Novel benzothiazole compounds and methods of use thereof

The present invention relates to methods of preparing compounds having formula (1), (2), (5), and ((6A)-(6D)) comprising contacting the corresponding ester, an amine with formula NHR1R2, and a Lewis acid having formula MLn, wherein L is a halogen atom or an organic radical, n is 3-5, and M is a group III elemental atom, a group IV elemental atom, As, Sb, V or Fe, wherein A, B, V, X, Z, W, R1, R2, R5, Z1, Z2, Z3, Z4, Z5, Z6, Z7, and Z8 are substituents. Z4, Z5, Z6, Z7, and Z8 are substituents.

A new class of histamine H3-receptor antagonists: Synthesis and structure - Activity relationships of 7,8,9,10-Tetrahydro-6H-cyclohepta[b]quinolines

The synthesis and biological evaluation of novel cycloheptaquinoline antagonists of the human H3 receptor are described. Two series of compounds, bearing either an amino substituent or an alkyne linker at the 11-position, were investigated. Modifications of the amino substituents, optimization of chain length and the effect of conformational restraints are described. Several compounds with high affinity and selectivity for the H3 receptor were discovered.